Impact Factor
3.20
Journal Citation Impact
Estimated influence, citation density, publishing volume, and citation integrity from the analytics table.
Citation rate
3.53
136 total citations
h5-index
16
h5 depth signal
Cited share
72.1%
31 of 43
Total citations
136
Citation footprint
Metric signal
3.88
External metric anchor
Self-citation
0.0%
0 self-citations
Citations Trend
Monthly Publications Cadence
Citing Geographic Demographics
China
101
United States
55
Turkey
27
Japan
21
Brazil
21
Citing Fields of Research
Obstetrics/Gynecology
377
Human Reproduction
40
Endocrinology & Metabolism
16
Noncoding RNA
16
Hematology
10
Publishing Activity & Reach
Volume, recency, access pattern, and citing-community signals from the journal analytics record.
All-time article footprint
1,255
Articles tracked across the journal lifetime
Indexed publication set
43
31 cited publications
Last 12 months
26
2.4 publications/month
Open access share
100.0%
26 OA publications in the last year
Leading citing country
China
101 citing publications
Leading citing field
Obstetrics/Gynecology
377 citing publications
Latest tracked publication
13 October 2026
10 recent records available
Coverage & Indexing History
v18n1, 1999-
v18n1, 1999-
Active Coverage
Research Focus & Classification
Indexed Subjects
Obstetrics/Gynecology
Issuing & Sponsoring Bodies
Contributor
International Society for the Study of Hypertension in Pregnancy
Broad Categories
Obstetrics
Vascular Diseases
Obstetrics/Gynecology
MeSH Descriptors
Hypertension
Pregnancy
Latest Publications
Recent article records with DOI-first linking and condensed abstracts.
01
DOI 10.1080/10641955.2026.2742300
Open DOI
Hypertensive disorders of pregnancy: epidemiology, pathophysiology, therapeutic strategies, and maternal-offspring outcomes
02
03
DOI 10.1080/10641955.2026.2707092
Open DOI
Towards an understanding of COVID-19-associated preeclampsia
During infectious disease outbreaks such as the COVID-19 (Coronavirus Disease 2019) pandemic, pregnant women represent a critically vulnerable population [1,2]. Pregnancy-induced physiological and ...
04
05
DOI 10.1080/10641955.2026.2708186
Open DOI
Biochemical markers of cardiac dysfunction in pregnancies with preeclampsia and fetal growth restriction
The exact pathophysiology of preeclampsia (PE) and fetal growth restriction (FGR) remains incompletely understood [1,2]. Traditionally, these complications have been attributed primarily to placent...
06
DOI 10.1080/10641955.2026.2725449
Open DOI
Hypertensive disorders during pregnancy and cognitive outcomes in children: the ALSPAC study
Hypertensive disorders during pregnancy, including gestational hypertension and pre-eclampsia, pose significant health risks to both mothers and infants, affecting approximately 5–10% of pregnancie...
07
DOI 10.1080/10641955.2026.2719498
Open DOI
Left ventricular hypertrophy as a predictor of adverse maternal and neonatal outcomes in chronic hypertension in pregnancy: a multicenter study
The impact of chronic hypertension (CHTN) combined with left ventricular hypertrophy (LVH) on adverse maternal and fetal pregnancy outcomes remains unclear. This multicenter retrospective cohort study included pregnant women with CHTN fr...
08
DOI 10.1080/10641955.2026.2708180
Open DOI
MIR210HG promotes preeclampsia progression through CDHR5
As a pregnancy-specific disease, preeclampsia (PE) occurs after 20 weeks of gestation and presents with a continuous progression of damage to multiple organs and systems, posing a considerable thre...
09
DOI 10.1080/10641955.2026.2694980
Open DOI
The economic burden of preeclampsia: a systematic review
Preeclampsia is a serious pregnancy complication associated with substantial maternal and infant morbidity worldwide. The adverse outcomes related to preeclampsia increase healthcare costs, highlighting the importance of quantifying its ...
10
DOI 10.1080/10641955.2026.2668801
Open DOI
Maternal hypertensive disorders in East Asia, 1990−2023: incidence, deaths, DALYs and maternal mortality in women aged 20−54 years using GBD 2023
Hypertensive disorders of pregnancy (HDP) are a major cause of illness and death and it can be prevented. We analysed Global Burden of Disease (GBD) 2023 estimates for maternal hypertensive disorders (ICD-10 O10-O16) in six locations (Ch...
Bibliographical & Catalog Notes
Title from cover.
Print issues ceased with v. 32 (2013).
Also issued online.
Official journal of the International Society for the Study of Hypertension in Pregnancy, 1993-2009.